# EMN26 (NCT04564703)

> Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04564703
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Stichting European Myeloma Network
- Conditions: Multiple Myeloma
- Interventions: Iberdomide
- Enrollment: 160
- Primary outcome: Efficacy: rate of improvement in response with iberdomide maintenance after autologous stem cell transplantation (ASCT)
- Primary outcome: Rate of dose reductions/discontinuations with iberdomide maintenance after ASCT

## Indexed commentary on EMN26 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- YouTube: 10
- Podcasts: 8
- X threads: 7
- Bluesky threads: 2

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=emn26-nct04564703

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04564703", "email": "<work email>"}; the inbox owner confirms by the emailed link.